Tech Company Financing Transactions
Kyron.bio Funding Round
On 5/29/2025, Kyron.bio raised $6 million in financing from HCVC, Entrepreneur First and Saras Capital.
Transaction Overview
Company Name
Announced On
5/29/2025
Transaction Type
Venture Equity
Amount
$5,950,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
27 rue du Faubourg Saint Jacques
Paris, 75014
FR
Paris, 75014
FR
Phone
Undisclosed
Website
Email Address
Overview
Kyron.bio is a Paris-based biotech company pioneering the use of glycan engineering to enhance the efficacy and safety of therapeutic proteins. Their innovative platform precisely controls glycosylation patterns, unlocking superior protein therapeutics and opening new avenues for drug development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emilia McLaughlin
Browse more venture capital transactions:
Prev: 5/29/2025: Empathy venture capital transaction
Next: 5/29/2025: FarmQA venture capital transaction
Share this article
Where The Data Comes From
We document tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs